4 completed. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow chiglitazar: new trials by email Literature Review of chiglitazar trials Research Report on chiglitazar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chiglitazar/Metformin in Non-obese Women With PCOS Chiglitazar, Metformin - Polycystic Ovary Syndrome, Chiglitazar | Phase 2 / Phase 3 | Completed | Shengjing Hospital | 55 | 2023-11-15 | 2025-01-01 |
| Chiglitazar Added to Metformin for Type 2 Diabetes Chiglitazar 32mg, Chiglitazar 48mg, Placebo - Type 2 Diabetes | Phase 3 | Completed | Chipscreen Biosciences, Ltd. | 533 | 2021-07-06 | 2024-07-15 |
| Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients Chiglitazar, Sitagliptin - Type 2 Diabetes | Phase 3 | Completed | Chipscreen Biosciences, Ltd. | 740 | 2014-09-01 | 2019-10-25 |
| Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients Chiglitazar, Placebo - Type 2 Diabetes | Phase 3 | Completed | Chipscreen Biosciences, Ltd. | 535 | 2014-06-01 | 2019-10-25 |
Diabetes Mellitus, Type 2 (3) · Diabetes Mellitus (1) · Polycystic Ovary Syndrome (1)
Chipscreen Biosciences, Ltd. (3) · Shengjing Hospital (1)
China (4)
Linong Ji, Dr. (1) · Linong Ji, Prof. (1) · Weiping Jia, Dr. (1)
PMID 35547000, PMID 36654286, PMID 36654287, PMID 38162801, PMID 40842343, PMID 41331576